Back to search
FDAFDA · Food and drugs·Recall number D-0771-2023

Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.

Published May 31, 2023 · Recall initiated: May 11, 2023

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub-potent Drug

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
Revive Rx LLC dba Revive Rx Pharmacy
Distributor
Nationwide in the US
Lot
Lot: 1643397 BUD: 10/16/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card